摘要
目的:对比观察极化液(氯化钾+胰岛素+葡萄糖)和参松养心胶囊治疗室性早搏的疗效和不良反应。方法:124例室性早搏病例被随机分为极化液组(62例)和参松组(62例),极化液组给予极化液和美托洛尔治疗,参松组给予参松养心胶囊并美托洛尔治疗,治疗2周后,观察两组室性早搏发作以及不良反应的情况。结果:治疗2周后,参松组控制室性早搏有效率明显优于极化液组(88.71%∶67.7%,P<0.05),出现的不良反应也明显少于极化液组(1.6%∶11.3%,P<0.05)。结论:参松养心胶囊治疗室性早搏的效果较极化液好,且不良反应少。
Objective：To observe and compare the therapeutic effects and adverse reactions of glucose＋insuline＋kalium（GIK）and Shensongyangxin capsule（Shensong）treating ventricular premature contraction（VPC）.Methods：A total of 124 VPC patients were randomly divided into GIK group（n=62） and Shensong group（n=62）.Patients in GIK group were given GIK solution and metoprolol while those in Shensong group were treated with Shensongyangxin capsule and metoprolol.After two weeks,the occurrence rate of VPC and drug adverse reaction were observed in the two groups.Results：After two weeks treatment,the effective rate of controlling VPC in Shensong group was significantly higher than that of GIK group（88.71% vs.67.7%,P0.05）,and occurrence rate of adverse reactions was significantly lower than that of GIK group（1.6% vs.11.3%,P0.05）.Conclusion：For treatment of ventricular premature contraction,Shensongyangxin capsule possesses better therapeutic effects and less adverse reactions than GIK solution.
出处
《心血管康复医学杂志》
CAS
2011年第1期88-89,共2页
Chinese Journal of Cardiovascular Rehabilitation Medicine
